JUST IN – Crew of “Andromeda” yacht, which is believed to be involved in the Nord…
Month: December 2023
Watched: Leave the World Behind, 2023 – ★★★
It kept grasping at straws to keep my attention. Source | Follow Frank on Letterboxd!
📰 UNITED STATES VETOES UN SECURITY COUNCIL DEMAND FOR IMMEDIATE HUMANITARIAN CEASEFIRE IN GAZA
UNITED STATES VETOES UN SECURITY COUNCIL DEMAND FOR IMMEDIATE HUMANITARIAN CEASEFIRE IN GAZA
📰 NOW – UN Security Council resolution calling for an “immediate ceasefire” in Gaza has been vetoed by the United States. https://t.co/641JyhWlzw
NOW – UN Security Council resolution calling for an “immediate ceasefire” in Gaza has been vetoed…
📰 *US IN TALKS WITH GULF ALLIES ON MILITARY ACTION AGAINST HOUTHIS
*US IN TALKS WITH GULF ALLIES ON MILITARY ACTION AGAINST HOUTHIS
📰 🔸Taylor Swift’s “Eras Tour” is the first tour to gross $1 billion, according to new data. The superstar’s tour brought in an estimated $1.04 billion this year, concert trade publication Pollstar said Friday. And it’s set to gross even more as the tour heads overseas. Swift… https://t.co/PUvlakhhj6
🔸Taylor Swift’s “Eras Tour” is the first tour to gross $1 billion, according to new data.…
📰 🔸Binance founder Changpeng Zhao is too rich to leave the U.S. before criminal sentencing, judge says Billionaire Binance founder Changpeng Zhao cannot leave the United States ahead of his criminal sentencing because of his “enormous wealth” and lack of U.S. ties, a federal… https://t.co/voEmu5kRRP
🔸Binance founder Changpeng Zhao is too rich to leave the U.S. before criminal sentencing, judge says…
📰 $MSFT 🔸US FTC IS EXAMINING THE NATURE OF MICROSOFT CORP.’S INVESTMENT IN OPENAI INC. AND WHETHER IT MAY VIOLATE ANTITRUST LAWS
$MSFT 🔸US FTC IS EXAMINING THE NATURE OF MICROSOFT CORP.’S INVESTMENT IN OPENAI INC. AND WHETHER…
📰 $CRSP 🔸 FDA Approves Vertex Pharmaceuticals and Crispr Therapeutics’ Casgevy for Sickle-Cell Disease — WSJ 🔸 Casgevy Is the First Approved Treatment Using Crispr Gene-Editing Technology — WSJ 🔸 Casgevy Helped Stop Nearly All Pain Crises from Sickle-Cell Disease in a Study… https://t.co/unrAWShv08
$CRSP 🔸 FDA Approves Vertex Pharmaceuticals and Crispr Therapeutics’ Casgevy for Sickle-Cell Disease — WSJ 🔸…